Navigation Links
BioMosaics' Glypican-3 Blood & Tissue Tests Receive CE Marking in Europe
Date:9/10/2007

past ten years and is expected to continue to rise over the next decade.

"BioMosaics recognizes the importance of developing new diagnostic tests that could more effectively target a specific type of cancer in the early stages. We are pleased that we have established these two high quality diagnostic products for the EU," said Dr. Ronald D. Guttmann, Executive VP Clinical Development.

About BioMosaics

BioMosaics is a biotechnology company located in Burlington, VT, engaged in the development and commercialization of innovative products for the early diagnosis, prediction, and monitoring of cancer.

Contacts:

BioMosaics Inc.

http://www.biomosaics.com

Mark Allegretta PhD; m.allegretta@biomosiacs.com

Ronald D. Guttmann MD; r.guttmann@biomosaics.com

+1-802-656-5443

Note: Statements in this news release that are not historical facts are "forward-looking statements" within the meaning given to that term in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby. Since these statements involve risks and uncertainties and are subject to change at any time, the Company's actual results could differ materially from expected results.


'/>"/>
SOURCE BioMosaics Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Rapid Whole Blood Testing for Infectious Mononucleosis Antibodies
2. Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing
3. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
4. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
5. New Data from Multiple Studies Show Galvus Delivers Consistent and Robust Blood Sugar Control in Patients with Type 2 Diabetes
6. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur
7. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
8. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
9. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
10. NCI Researchers Discover Genes That Are Turned on at High Levels in Tumor-associated Blood Vessels of Mice and Humans
11. Blood Levels of Paliperidone Extended-Release Tablets are Not Increased by Common Antidepressant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... WASHINGTON , July 22, 2014  Edwards Lifesciences ... in the science of heart valves and hemodynamic monitoring, ... Mussallem today served as an expert panelist at ... Committee,s Subcommittee on Health to discuss medical device innovation ... Barriers to Ongoing Evidence Development and Communication." ...
(Date:7/22/2014)... The National Space Biomedical Research Institute (NSBRI) will establish, ... (CSRR) under the leadership of Marjan Boerma , ... Sciences within the University of Arkansas for Medical Sciences ... is located in Little Rock, AR ... across four U.S. institutions, to implement the 3 year ...
(Date:7/22/2014)... 22, 2014 Legislation backed by the ... Local Pharmacies Act of 2014") championing so-called "any ... undermine the availability of lower cost preferred pharmacy ... over the next 10 years, according to new ... Pharmaceutical Care Management Association (PCMA). The ...
Breaking Medicine Technology:Edwards' CEO Invited To Address Congress On Opportunities To Revitalize Medical Device Innovation 2Boerma Led UAMS Team to Establish NSBRI's Center for Space Radiation Research (CSRR) 2Boerma Led UAMS Team to Establish NSBRI's Center for Space Radiation Research (CSRR) 3New Study: H.R. 4577 to Cost $21 Billion over 10 Years 2New Study: H.R. 4577 to Cost $21 Billion over 10 Years 3
... Reportlinker.com announces that a new market research ... Chinese Pharmaceutical Regulatory Report 2011 ... This report includes a brief ... in China, as well as a discussion ...
... 25, 2011 Reportlinker.com announces that a ... its catalogue: Triple Analysis: ... http://www.reportlinker.com/p0284719/Triple-Analysis-Lymphoma-Prostate-Cancer-and-Antibodies.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology This ... strategies in both Lymphoma and Prostate Cancer ...
Cached Medicine Technology:Reportlinker Adds Chinese Pharmaceutical Regulatory Report 2011 2Reportlinker Adds Triple Analysis: Lymphoma, Prostate Cancer and Antibodies 2Reportlinker Adds Triple Analysis: Lymphoma, Prostate Cancer and Antibodies 3Reportlinker Adds Triple Analysis: Lymphoma, Prostate Cancer and Antibodies 4Reportlinker Adds Triple Analysis: Lymphoma, Prostate Cancer and Antibodies 5
(Date:7/22/2014)... 2014 Obtaining a bachelor’s degree in ... who have hands-on medical experience. The School of Nursing ... announced the launch of an accelerated nursing degree program ... new program, the UNCG Veterans Access Program (VAP), will ... veterans. With some prior college credit, veterans who are ...
(Date:7/22/2014)... San Antonio, TX (PRWEB) July 22, 2014 ... website. Designed with existing patients and new visitors in mind, ... a clean, modern and visual layout that makes navigation very ... to make the experience of going to the dentist affordable, ... , One helpful new feature is an appointment scheduling ...
(Date:7/22/2014)... Indianapolis, IN (PRWEB) July 22, 2014 ... benefits advisory organization, announces that Les McPhearson, an insurance ... serve as CEO effective immediately and be based in ... Calise, said, "I am delighted that Les chose to ... is perfectly qualified to address the many challenges facing ...
(Date:7/22/2014)... Steven Reinberg HealthDay Reporter ... break up blood clots deep in the veins of the ... one results in a greater risk of bleeding and average ... other treatment, a new study finds. The standard treatment ... -- is blood-thinning medications and compression stockings. The other, more ...
(Date:7/22/2014)... (WASHINGTON, July 22, 2014) The American Society of ... Vanderbilt University School of Medicine, and Robert P. Hebbel, ... the 2014 Ernest Beutler Lecture and Prize for their ... disease. , The Ernest Beutler Lecture, named for the ... and physician-scientist for more than 50 years, is a ...
Breaking Medicine News(10 mins):Health News:UNCG School of Nursing Fast-Tracks Medically Trained Veterans 2Health News:Dr. Dental Reveals Exciting New Website 2Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 2Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 3Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 4Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 5Health News:Study Casts Doubt on Costly Treatment for Leg Clots 2Health News:Study Casts Doubt on Costly Treatment for Leg Clots 3Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 2Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 3Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 4
... Health (HSPH) researchers found that just 40% of adults are ... and 51% of parents are "absolutely certain" that they will ... reasoning among those who said they would not get the ... series of surveys of public views concerning the H1N1 flu ...
... Researchers at Fox Chase Cancer Center have demonstrated that a ... most aggressive forms of breast cancer to grow. Their findings, ... cancer, are presented in a recent issue of Cancer ... we have been able to present evidence that directly demonstrates ...
... ... Crothall is contending with these potential changes by launching two initiatives this fall. First, ... entire customer base. Coinciding with the analysis, they are introducing their GreenChoices program to ... ...
... signs of slowing, researchers say , FRIDAY, Oct. ... more than half of babies born in rich nations since ... have less disability than elderly people in previous generations. , ... life expectancy evident in rich nations since 1840 show no ...
... ... ... -- Finding information to provide essential and practical aid and care during serious situations is ... not be able to deliver a timely response, or to administer self-care without a costly ...
... , BALTIMORE, Oct. 2 As part of a ... cosmetic specialists in their areas, the online consumer advocacy ... addition of three esteemed Baltimore plastic surgeons to its ... Basner, Dr. Lawrence Rosenberg and Dr. Daniel P. Markmann ...
Cached Medicine News:Health News:Survey finds just 40 percent of adults 'absolutely certain' they will get H1N1 vaccine 2Health News:Survey finds just 40 percent of adults 'absolutely certain' they will get H1N1 vaccine 3Health News:Survey finds just 40 percent of adults 'absolutely certain' they will get H1N1 vaccine 4Health News:NEDD9 protein supports growth of aggressive breast cancer 2Health News:As Environmental Regulations Gather on the Horizon, Crothall Services Group Launches Green Initiatives to Assist Hospitals 2Health News:As Environmental Regulations Gather on the Horizon, Crothall Services Group Launches Green Initiatives to Assist Hospitals 3Health News:Half of U.S. Babies Living Today May Reach 100 2Health News:Half of U.S. Babies Living Today May Reach 100 3Health News:VisionSync Launches a Smart iPhone First Aid App, iMobile Care 2Health News:VisionSync Launches a Smart iPhone First Aid App, iMobile Care 3Health News:Leading Baltimore Plastic Surgeons Join Plastic Surgery Portal Network 2
... The PhacoFlexII SI30NB is ... incision to it's patients. It ... tools. The SI30NB is indicated ... visual correction of aphakia in ...
... USIOL lenses are manufactured using ... processes. Perspex CQ UV PMMA ... multi-piece and single piece lenses. ... in both nonphaco and phaco ...
... Posterior Chamber Lenses: The Bausch & Lomb PMMA ... used for primary implantation for the visual correction ... or older where a cataractous lens has been ... intended to be placed in the ciliary sulcus ...
Single piece Anterior Chamber PMMA lens, AC depth: 4.9....
Medicine Products: